Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP979731.RAt22VTRb7tifmp-Hx0b86M4yLER4tE7vqUK_l2Cu1CuQ130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP979731.RAt22VTRb7tifmp-Hx0b86M4yLER4tE7vqUK_l2Cu1CuQ130_assertion type Assertion NP979731.RAt22VTRb7tifmp-Hx0b86M4yLER4tE7vqUK_l2Cu1CuQ130_head.
- NP979731.RAt22VTRb7tifmp-Hx0b86M4yLER4tE7vqUK_l2Cu1CuQ130_assertion description "[Expression of TSP-1 and TSP-2 was detected in 33 (60.0%) and 15 cases (27.3%), respectively, of 55 endometrial cancer samples.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP979731.RAt22VTRb7tifmp-Hx0b86M4yLER4tE7vqUK_l2Cu1CuQ130_provenance.
- NP979731.RAt22VTRb7tifmp-Hx0b86M4yLER4tE7vqUK_l2Cu1CuQ130_assertion evidence source_evidence_literature NP979731.RAt22VTRb7tifmp-Hx0b86M4yLER4tE7vqUK_l2Cu1CuQ130_provenance.
- NP979731.RAt22VTRb7tifmp-Hx0b86M4yLER4tE7vqUK_l2Cu1CuQ130_assertion SIO_000772 11445843 NP979731.RAt22VTRb7tifmp-Hx0b86M4yLER4tE7vqUK_l2Cu1CuQ130_provenance.
- NP979731.RAt22VTRb7tifmp-Hx0b86M4yLER4tE7vqUK_l2Cu1CuQ130_assertion wasDerivedFrom befree-20150227 NP979731.RAt22VTRb7tifmp-Hx0b86M4yLER4tE7vqUK_l2Cu1CuQ130_provenance.
- NP979731.RAt22VTRb7tifmp-Hx0b86M4yLER4tE7vqUK_l2Cu1CuQ130_assertion wasGeneratedBy ECO_0000203 NP979731.RAt22VTRb7tifmp-Hx0b86M4yLER4tE7vqUK_l2Cu1CuQ130_provenance.